Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Study to Evaluate the Sustained Clinical Efficacy of Ragweed MATA MPL (Allergy Therapeutics®) in Patients With Ragweed-induced Seasonal Allergic Rhinitis Upon Re-exposure to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Model, Approximately One Year After Pre-seasonal Treatment in 2005

NCT00325338 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00325338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00325338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Study to Evaluate the Sustained Clinical Efficacy of Ragweed MATA MPL (Allergy Therapeutics®) in Patients With Ragweed-induced Seasonal Allergic Rhinitis Upon Re-exposure to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Model, Approximately One Year After Pre-seasonal Treatment in 2005
Lead sponsor
Allergy Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
July 31, 2006
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity